Ayala Pharmaceuticals and Biosight Enter into Definitive Merger Agreement

Provided By GlobeNewswire

Last update: Jul 27, 2023

Combined company to operate as Ayala Pharmaceuticals, Inc.

Merger to add a clinical stage oncology asset to Ayala’s portfolio with data anticipated in the first half of 2024